Expression of cytochrome P450 and MDR1 in patients with proctitis

Upsala Journal of Medical Sciences

Volumn 112, Issue 3, 2007, Pages 303-312

  Thörn, Mari ^a,c,d   Finnström, Niklas ^b   Lundgren, Stefan ^b   Rane, Anders ^b   Lööf, Lars ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^d MEDICAL PRODUCTS AGENCY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ABCB1 PROTEIN, HUMAN; COMPLEMENTARY DNA; CYTOCHROME P450; GLYCOPROTEIN P; MESSENGER RNA;

ADULT; AGED; ARTICLE; ENZYMOLOGY; FEMALE; GENETICS; HUMAN; MALE; METABOLISM; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROCTITIS;

ADULT; AGED; CYTOCHROME P-450 ENZYME SYSTEM; DNA, COMPLEMENTARY; FEMALE; HUMANS; MALE; MIDDLE AGED; P-GLYCOPROTEIN; POLYMERASE CHAIN REACTION; PROCTITIS; RNA, MESSENGER;

EID: 48949107449     PISSN: 03009734     EISSN: None     Source Type: Journal    
DOI: 10.3109/2000-1967-203     Document Type: Article

References (36)

1. Nebert, D. W. and Russell, D. W. (2002) Clinical importance of the cytochromes P450 Lancet 360: 1155-1162
2. Ueda, K., Cornwell, M. M., Gottesman, M. M., Pastan, I., Roninson, I. B., Ling, V. and Riordan, J. R. (1986) The mdr1 gene, responsible for multidrug-resistance, codes for P-glycoprotein Biochem Biophys Res Commun 141: 956-962
3. Willingham, M. C., Cornwell, M. M., Cardarelli, C. O., Gottesman, M. M. and Pastan, I. (1986) Single cell analysis of daunomycin uptake and efflux in multidrug-resistant and -sensitive KB cells: effects of verapamil and other drugs Cancer Res 46: 5941-5946
4. Wu, C. Y., Benet, L. Z., Hebert, M. F., Gupta, S. K., Rowland, M., Gomez, D. Y. and Wacher, V. J. (1995) Differentiation of absorption and first-pass gut and hepatic metabolism in humans: studies with cyclosporine Clin Pharmacol Ther 58: 492-497
5. Klotz, U., Hoensch, H., Schütz, T., Beaune, P., Zanger, U., Bode, J. C. and Fritz, P. (1998) Expression of intestinal drug-metabolising enzymes in patients with chronic inflammatory bowel disease. Current Theapeutic Research 556-563
6. McKinnon, R. A., Burgess, W. M., Hall, P. M., Roberts-Thomson, S. J., Gonzalez, F. J. and Mc-Manus, M. E. (1995) Characterisation of CYP3A gene subfamily expression in human gastrointestinal tissues Gut 36: 259-267
7. Kolars, J. C., Lown, K. S., Schmiedlin-Ren, P., Ghosh, M., Fang, C., Wrighton, S. A., Merion, R. M. and Watkins, P. B. (1994) CYP3A gene expression in human gut epithelium Pharmacogenetics 4: 247-259
8. Thorn, M., Finnstrom, N., Lundgren, S., Rane, A. and Loof, L. (2005) Cytochromes P450 and MDR1 expression gradients along the human gastrointestinal tract. Brit. J Clinical Pharm 60: 54-60
9. Xu, C. T., Meng, S. Y. and Pan, B. R. (2004) Drug therapy for ulcerative colitis World J Gastroenterol 10: 2311-2317
10. Griffin, M. G. and Miner, P. B. (1996) Review article: refractory distal colitis - explanations and options Aliment Pharmacol Ther 10: 39-48
11. Farrell, R. J., Murphy, A., Long, A., Donnelly, S., Cherikuri, A., O'Toole, D., Mahmud, N., Keeling, P. W., Weir, D. G. and Kelleher, D. (2000) High multidrug resistance (P-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapy Gastroenterology 118: 279-288
12. Ingelman-Sundberg, M., Oscarson, M. and McLellan, R. A. (1999) Polymorphic human cytochrome P450 enzymes: an opportunity for individualized drug treatment Trends Pharmacol Sci 20: 342-349
13. Brant, S. R., Panhuysen, C. I., Nicolae, D., Reddy, D. M., Bonen, D. K., Karaliukas, R., Zhang, L., Swanson, E., Datta, L. W., Moran, T., Ravenhill, G., Duerr, R. H., Achkar, J. P., Karban, A. S. and Cho, J. H. (2003) MDR1 Ala893 polymorphism is associated with inflammatory bowel disease Am J Hum Genet 73: 1282-1292
14. Renton, K. W. (2001) Alteration of drug biotransformation and elimination during infection and inflammation Pharmacol Ther 92: 147-163
15. Morgan, E. T. (2001) Regulation of cytochrome p450 by inflammatory mediators: why and how? Drug Metab Dispos 29: 207-212
16. Bertilsson, P. M., Olsson, P. and Magnusson, K. E. (2001) Cytokines influence mRNA expression of cytochrome P450 3A4 and MDRI in intestinal cells J Pharm Sci 90: 638-646
17. Panwala, C. M., Jones, J. C. and Viney, J. L. (1998) A novel model of inflammatory bowel disease: mice deficient for the multiple drug resistance gene, mdr1a, spontaneously develop colitis J Immunol 161: 5733-5744
18. Ho, G. T., Moodie, F. M. and Satsangi, J. (2003) Multidrug resistance 1 gene (P-glycoprotein 170): an important determinant in gastrointestinal disease? Gut 52: 759-766
19. Schwab, M., Schaeffeler, E., Marx, C., Fromm, M. F., Kaskas, B., Metzler, J., Stange, E., Herfarth, H., Schoelmerich, J., Gregor, M., Walker, S., Cascorbi, I., Roots, I., Brinkmann, U., Zanger, U. M. and Eichelbaum, M. (2003) Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis Gastroenterology 124: 26-33
20. Glas, J., Torok, H. P., Schiemann, U. and Folwaczny, C. (2004) MDR1 gene polymorphism in ulcerative colitis Gastroenterology 126: 367
21. Gazouli, M., Zacharatos, P., Gorgoulis, V., Mantzaris, G., Papalambros, E. and Ikonomopoulos, J. (2004) The C3435T MDR1 gene polymorphism is not associated with susceptibility for ulcerative colitis in Greek population Gastroenterology 126: 367-369
22. Croucher, P. J., Mascheretti, S., Foelsch, U. R., Hampe, J. and Schreiber, S. (2003) Lack of association between the C3435T MDR1 gene polymorphism and inflammatory bowel disease in two independent Northern European populations Gastroenterology 125: 1919-1920; author reply 1920-1911
23. Bowen, W. P., Carey, J. E., Miah, A., McMurray, H. F., Munday, P. W., James, R. S., Coleman, R. A. and Brown, A. M. (2000) Measurement of cytochrome P450 gene induction in human hepatocytes using quantitative real-time reverse transcriptase-polymerase chain reaction Drug Metab Dispos 28: 781-788
24. Finnstrom, N., Thorn, M., Loof, L. and Rane, A. (2001) Independent patterns of cytochrome P450 gene expression in liver and blood in patients with suspected liver disease Eur J Clin Pharmacol 57: 403-409
25. Thorn, M., Lundgren, S., Herlenius, G., Ericzon, B. G., Loof, L. and Rane, A. (2004) Gene expression of cytochromes P(450) in liver transplants over time Eur J Clin Pharmacol 60: 413-420
26. George, J., Liddle, C., Murray, M., Byth, K. and Farrell, G. C. (1995) Pre-translational regulation of cytochrome P450 genes is responsible for disease-specific changes of individual P450 enzymes among patients with cirrhosis Biochem Pharmacol 49: 873-881
27. Sumida, A., Kinoshita, K., Fukuda, T., Matsuda, H., Yamamoto, I., Inaba, T. and Azuma, J. (1999) Relationship between mRNA levels quantified by reverse transcription-competitive PCR and metabolic activity of CYP3A4 and CYP2E1 in human liver Biochem Biophys Res Commun 262: 499-503
28. Rodriguez-Antona, C., Donato, M. T., Pareja, E., Gomez-Lechon, M. J. and Castell, J. V. (2001) Cytochrome P-450 mRNA expression in human liver and its relationship with enzyme activity Arch Biochem Biophys 393: 308-315
29. Kuehl, P., Zhang, J., Lin, Y., Lamba, J., Assem, M., Schuetz, J., Watkins, P. B., Daly, A., Wrighton, S. A., Hall, S. D., Maurel, P., Relling, M., Brimer, C., Yasuda, K., Venkataramanan, R., Strom, S., Thummel, K., Boguski, M. S. and Schuetz, E. (2001) Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression Nat Genet 27: 383-391
30. Lown, K. S., Kolars, J. C., Thummel, K. E., Barnett, J. L., Kunze, K. L., Wrighton, S. A. and Watkins, P. B. (1994) Interpatient heterogeneity in expression of CYP3A4 and CYP3A5 in small bowel. Lack of prediction by the erythromycin breath test Drug Metab Dispos 22: 947-955
31. Stephens, R. H., Tanianis-Hughes, J., Higgs, N. B., Humphrey, M. and Warhurst, G. (2002) Region-dependent modulation of intestinal permeability by drug efflux transporters: in vitro studies in mdr1a(-/-) mouse intestine J Pharmacol Exp Ther 303: 1095-1101
32. Fojo, A. T., Ueda, K., Slamon, D. J., Poplack, D. G., Gottesman, M. M. and Pastan, I. (1987) Expression of a multidrug-resistance gene in human tumors and tissues Proc Natl Acad Sci U S A 84: 265-269
33. Piquette-Miller, M., Pak, A., Kim, H., Anari, R. and Shahzamani, A. (1998) Decreased expression and activity of P-glycoprotein in rat liver during acute inflammation Pharm Res 15: 706-711
34. McRae, M. P., Brouwer, K. L. and Kashuba, A. D. (2003) Cytokine regulation of P-glycoprotein Drug Metab Rev 35: 19-33
35. Saclarides, T. J., Jakate, S. M., Coon, J. S., Bhattacharyya, A. K., Dominguez, J. M., Szeluga, D. J. and Weinstein, R. S. (1992) Variable expression of P-glycoprotein in normal, inflamed, and dysplastic areas in ulcerative colitis Dis Colon Rectum 35: 747-752
36. Goto, M., Masuda, S., Saito, H. and Inui, K. (2003) Decreased expression of P-glycoprotein during differentiation in the human intestinal cell line Caco-2 Biochem Pharmacol 66: 163-170